Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,301 signal articles · 47 in last 24h · 115,578 total before filter · latest 19m ago
47last 24h
1766last 7d
301● bullish (7d)
168● bearish (7d)
205publishers
AllMacro314Earnings819M&A103Regulatory25Product16Analyst26
✕ clear all filterssentiment: bearishSentiment:bullishneutralbearishshow all (incl. clickbait)
Investing.com32d agobearish
Dell leads broader AI hardware selloff as shares tumble 14%

The selloff extends well beyond Dell. Hewlett Packard Enterprise is sliding roughly 8% and Super Micro Computer is off around 5%, confirming the move is concentrated in high-beta AI hardware names rather than broad technology. The Nasdaq-100 ETF (QQQ) is down about 1% on the session.

SpaceX Shares Fall Below IPO Price for the First Time
The Wall Street Journal32d agobearish
SpaceX Shares Fall Below IPO Price for the First Time

Shares slipped 2.5% to $132.72 in recent trading. Over the past month they have edged lower; even SpaceX’s addition to the Nasdaq-100 index didn’t boost them. SpaceX is hardly the first big IPO to struggle in early days or weeks of trading.

Elevance Stock Falls on Medicaid Concerns
The Wall Street Journal32d agobearish
Elevance Stock Falls on Medicaid Concerns

Skittish investors pushed Elevance shares down, as they focused on worries about its Medicaid business. CEO Gail Boudreaux said the insurer’s Medicaid results were roughly what it expected, but the company is leaving the District of Columbia’s Medicaid market and plans to exit others over the next year to 18 months.

Celcuity shares fall as delayed breast cancer drug launch eclipses first US FDA approval
Reuters32d agobearish
Celcuity shares fall as delayed breast cancer drug launch eclipses first US FDA approval

July 15 () - Shares of Celcuity fell about 8% in premarket trading on Wednesday, as the delayed commercial launch ‌of its newly approved breast cancer drug and treatment-tolerability ‌concerns overshadowed the company's first U. Food and Drug Administration on ​Tuesday approved gedatolisib, branded as Revtorpyk, for certain patients with advanced breast cancer whose tumors do not carry a PIK3CA mutation.

SpaceX Stock Is in a Bear Market. This Can Turn It Around.
Barrons.com32d agobearish
SpaceX Stock Is in a Bear Market. This Can Turn It Around.

SpaceX stock is dangerously close to breaking its $135 IPO price. SpaceX is set to test its huge, fully-reusable Starship for the thirteenth time. Starship promises to dramatically lower the cost of reaching space while dramatically increasing SpaceX’s capacity to put things into orbit.

Bloomberg32d agobearish
JPMorgan’s Faller Sees AI Opportunities Beyond Big Tech Stocks

(Bloomberg) -- Investors should look across the entire artificial intelligence value chain rather than focus on Big Tech alone, according to JPMorgan Private Bank’s Madison Faller. Most Read from BloombergThailand Scraps Plan to End Visa-Free Entry for Indian TouristsTrump Drops 20% Fee for Hormuz Cargo After Gulf PressureUS Hits Iran With Strikes, Blockade as Trump Plans Hormuz ChargeOpenAI’s First Device Will Be Movable, Screenless Speaker Built as AI Companion‘We Faltered’: IBM Plunges Most S

Meta employees allege discriminatory AI-driven layoffs
AFP32d agobearish
Meta employees allege discriminatory AI-driven layoffs

Twenty-six Meta employees have filed a lawsuit accusing the tech giant of using artificial intelligence to select workers for mass layoffs, a claim strongly denied by the trillion dollar company.According to the lawsuit, filed in Oakland, California on Monday Meta used AI systems to "score, rank, and select employees" to be laid off rather than "the considered judgement of managers who knew the work" while disproportionately targeting those on medical or family leave.

Walmart’s 7,200 price cuts land heaviest in one category
TheStreet32d agobearish
Walmart’s 7,200 price cuts land heaviest in one category

Walmart has lowered prices on a range of grocery staples, including ground beef, corn on the cob, cherries, and 24-packs of soda. The nation’s largest retailer recently unveiled a summer rollback campaign covering thousands of products across groceries, household essentials, and seasonal goods ...